Patients with glioblastoma—the deadliest type of primary brain tumor—may potentially benefit from immunotherapy medications called immune checkpoint inhibitors that stimulate an immune response against cancer cells.
Feb 2, 2023
0
30
A randomized, double blind human clinical trial conducted by researchers at Baylor College of Medicine reveals that supplementation with GlyNAC—a combination of glycine and N-acetylcysteine—improves many age-associated ...
Aug 18, 2022
4
763
Antiplatelet drugs such as aspirin have little effect on the need for life support in COVID-19, but they may improve survival in the following months.
Mar 22, 2022
0
71
Adolescents born prematurely present a high risk of developing executive, behavioral and socio-emotional difficulties. Now, researchers from Geneva University Hospitals (HUG) and the University of Geneva (UNIGE) have revealed ...
Oct 6, 2021
0
36
Rethinking what causes pain and how great of a threat it is can provide chronic pain patients with lasting relief and alter brain networks associated with pain processing, according to new University of Colorado Boulder-led ...
Sep 29, 2021
0
87
An avocado a day could help redistribute belly fat in women toward a healthier profile, according to a new study from the University of Illinois Urbana-Champaign and collaborators.
Sep 6, 2021
0
210
Back problems are among the most common causes of sick leave. Every year as many as one in 15 adults in Norway sees a doctor or physiotherapist due to lower back pain. Worldwide, back pain is the most common cause of disability.
Aug 2, 2021
1
444
New research published this week challenges a popular belief that intermittent fasting diets such as alternate day fasting or the '5:2' are the most effective ways to lose weight.
Jun 16, 2021
0
132
A vast majority of doctors and parents of babies in intensive care, with diseases of unknown origin, believe genomic sequencing is beneficial in managing care, according to two new papers published by Rady Children's Institute ...
Nov 5, 2020
0
27
Cholesterol-lowering drugs called statins may reduce cancer risk in humans through a pathway unrelated to cholesterol, says a study published today in eLife.
Oct 13, 2020
0
362
